Isoflurane
- Generic Name
- Isoflurane
- Brand Names
- Forane, Terrell
- Drug Type
- Small Molecule
- Chemical Formula
- C3H2ClF5O
- CAS Number
- 26675-46-7
- Unique Ingredient Identifier
- CYS9AKD70P
- Background
A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
- Indication
For induction and maintenance of general anesthesia.
- Associated Conditions
- -
- Associated Therapies
- Induction and Maintenance of General Anesthesia
Sevoflurane/Dexmedetomidine Vs. Isoflurane for Pediatric Emergence Delirium
- Conditions
- Interventions
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 400
- Registration Number
- NCT06624592
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Evaluation of the Safety of Inhaled Sedation With Isoflurane in Head Trauma Patients
- First Posted Date
- 2024-03-15
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- University Hospital, Grenoble
- Target Recruit Count
- 30
- Registration Number
- NCT06311604
- Locations
- 🇫🇷
University Hospital Grenoble, Grenoble, Choisir Une Région, France
Desflurane Versus Isoflurane for Speeding Postanesthetic Recovery and Hospital Discharge
- First Posted Date
- 2024-02-09
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 2619
- Registration Number
- NCT06252207
Volatile Sedation for Patients With the Acute Respiratory Distress Syndrome
- Conditions
- Interventions
- First Posted Date
- 2023-08-28
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Target Recruit Count
- 20
- Registration Number
- NCT06014138
- Locations
- 🇬🇧
Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom
Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus
- First Posted Date
- 2023-04-26
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Hopital of Melun
- Target Recruit Count
- 120
- Registration Number
- NCT05830864
- Locations
- 🇫🇷
Ch Bethune Beuvry, Beuvry, France
🇫🇷CHU Brest, Brest, France
🇫🇷GH Sud Ile de France, Hôpital de Melun-Sénart, Melun, France
Effect of Anesthetics on Troponin I and С-reactive Protein
- Conditions
- Interventions
- First Posted Date
- 2023-02-24
- Last Posted Date
- 2023-06-05
- Lead Sponsor
- Astana Medical University
- Target Recruit Count
- 255
- Registration Number
- NCT05742789
- Locations
- 🇰🇿
Bekzat, Astana, Kazakhstan
The Effects of Sevoflurane, Isoflurane and Propofol During Cardiac Surgery
- Conditions
- Interventions
- First Posted Date
- 2023-01-25
- Last Posted Date
- 2023-01-25
- Lead Sponsor
- Astana Medical University
- Target Recruit Count
- 89
- Registration Number
- NCT05695287
- Locations
- 🇰🇿
Bekzat, Astana, Kazakhstan
Influence of Anesthetics on Clinical Outcome in Mitral and Aortic Valve Replacement in Adults
- Conditions
- Interventions
- First Posted Date
- 2023-01-25
- Last Posted Date
- 2023-01-25
- Lead Sponsor
- Astana Medical University
- Target Recruit Count
- 75
- Registration Number
- NCT05696509
- Locations
- 🇰🇿
Bekzat, Astana, Kazakhstan
Influence of Anesthetics on Clinical Outcome During Cardiac Surgery in Adults
- Conditions
- Interventions
- First Posted Date
- 2023-01-23
- Last Posted Date
- 2023-01-23
- Lead Sponsor
- Astana Medical University
- Target Recruit Count
- 90
- Registration Number
- NCT05693428
- Locations
- 🇰🇿
Bekzat, Astana, Kazakhstan
Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Sedana Medical
- Target Recruit Count
- 235
- Registration Number
- NCT05327296
- Locations
- 🇺🇸
Memorial Health Services, Long Beach, California, United States
🇺🇸University of Miami, Coral Gables, Florida, United States
🇺🇸The New York and Presbyterian Hospital, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.